Rx-to-OTC Switching Market Industry Market & Its Areas of Potential Growth.
Rx-to-OTC Switching market report of 70+ pages covers Rx-to-OTC Switching analysis, Rx-to-OTC Switching market size with focus on trends, developments, mergers and acquisitions, Rx-to-OTC Switching market share analysis, Rx-to-OTC Switching companies both
(EMAILWIRE.COM, May 04, 2018 ) MarketIntelReports, Singapore, April 27, 2018.
MarketIntelReports : A global report titled Rx-to-OTC Switching Market has been introduced into our library of 2.5 million reports.
Title of the report: Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders
Year: 2018
Details in the report: This is a 72 page report with 10 chapters which includes demand analysis by country, application, manufacturers, product categories. Report also includes key developments, market share analysis, market sizing by country, market trends/ future trends, strategic initiatives, key product launches as well.
About the market report:
Rx-to-OTC switching is the process in which a drug which has formerly been marketed as a prescription-only Rx drug is authorized for sale to the general public, without the need for a prescription. For patients and healthcare providers, OTC products can reduce the cost of medical treatment and allow easier access of drugs to patients, and for pharmaceutical companies, they allow lifecycle extension of an off-patent drug by transferring it to the consumer environment, and facilitate renewed revenue growth.
Based on overall revenue, the OTC pharmaceutical market has been dominated by four main categories: cough, cold, and allergy; analgesics; dermatologicals; and gastrointestinals. These categories have led the OTC drugs market over the last two decades in revenue and volume.
GBI Research conducted a targeted industry survey of experts and key opinion leaders (KOL) in the field of Rx-to-OTC switching to gather insight and opinions on the trends and commercial prospects of switching pharmaceuticals. The majority of these respondents believe that there will be an increase in Rx-to-OTC switching in the next five years, particularly in the weight control, dermatological and cough, cold and allergy segments.
To access the full table of contents of the report click below:
Link to the table of contents:https://www.marketintelreports.com/report/cbr0004/current-and-future-trends-in-rxtootc-switching-with-insight-from-key-industry-opinion-leaders
Scope of the Report:
- What are the characteristics of an ideal Rx-to-OTC switching candidate?
- How well have recent Rx-to-OTC switches performed, and into which therapeutic categories do they fall?
- What are the key drivers and barriers of the global OTC market?
- What are the key future trends that will influence the OTC market and Rx-to-OTC switches worldwide?
- Which disease areas do industry professionals believe to hold the most opportunity for switches?
- Which geographies hold the most potential for an OTC product, and which are the most amenable to Rx-to-OTC switching?
Key Reasons to Purchase
- Gain a thorough understanding of Rx-to-OTC switching, including key concepts, the regulatory environment and geographic variations.
- Understand the competitive environment of key disease areas in the OTC product space.
- Identify the drug classes and indications which pharmaceutical professionals around the world believe hold the most opportunity for Rx-to-OTC switching.
- Understand in depth the key trends driving and holding back the OTC market, both globally and within specific geographies.
There are 10 Chapters to deeply display the Rx-to-OTC Switching market.
To find out more of the report or request some customization :
Link to the Inquiry before purchase:https://www.marketintelreports.com/inquiry-before-buying.php?id=cbr0004
Table of Contents-Key Points Covered – Partial paste
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Rx-to-OTC Switching Overview 7
2.1 What is Rx-to-OTC switching? 7
3 Leading Product Categories in the OTC Drugs Market 10
………….
8 Other Geographic Trends and Insights 56
8.1 Australia 56
8.2 Canada 56
8.3 China 57
8.4 Germany 58
8.5 Poland 58
8.6 South Korea 59
8.7 Sweden 59
8.8 Russia 60
8.9 Greatest Revenue-Generating OTC Markets 60
8.10 In Which Countries is Reverse Switching a Possibility? 61
Continued…..
Complete Report Details @https://www.marketintelreports.com/report/cbr0004/current-and-future-trends-in-rxtootc-switching-with-insight-from-key-industry-opinion-leaders
Contact us for any queries on the report:
Lakshmi
Sales Manager
Email : sales@marketintelreports.com
www.marketintelreports.com
Contact Sales: 1-302-261-5343
About us:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
MarketIntelReports : A global report titled Rx-to-OTC Switching Market has been introduced into our library of 2.5 million reports.
Title of the report: Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders
Year: 2018
Details in the report: This is a 72 page report with 10 chapters which includes demand analysis by country, application, manufacturers, product categories. Report also includes key developments, market share analysis, market sizing by country, market trends/ future trends, strategic initiatives, key product launches as well.
About the market report:
Rx-to-OTC switching is the process in which a drug which has formerly been marketed as a prescription-only Rx drug is authorized for sale to the general public, without the need for a prescription. For patients and healthcare providers, OTC products can reduce the cost of medical treatment and allow easier access of drugs to patients, and for pharmaceutical companies, they allow lifecycle extension of an off-patent drug by transferring it to the consumer environment, and facilitate renewed revenue growth.
Based on overall revenue, the OTC pharmaceutical market has been dominated by four main categories: cough, cold, and allergy; analgesics; dermatologicals; and gastrointestinals. These categories have led the OTC drugs market over the last two decades in revenue and volume.
GBI Research conducted a targeted industry survey of experts and key opinion leaders (KOL) in the field of Rx-to-OTC switching to gather insight and opinions on the trends and commercial prospects of switching pharmaceuticals. The majority of these respondents believe that there will be an increase in Rx-to-OTC switching in the next five years, particularly in the weight control, dermatological and cough, cold and allergy segments.
To access the full table of contents of the report click below:
Link to the table of contents:https://www.marketintelreports.com/report/cbr0004/current-and-future-trends-in-rxtootc-switching-with-insight-from-key-industry-opinion-leaders
Scope of the Report:
- What are the characteristics of an ideal Rx-to-OTC switching candidate?
- How well have recent Rx-to-OTC switches performed, and into which therapeutic categories do they fall?
- What are the key drivers and barriers of the global OTC market?
- What are the key future trends that will influence the OTC market and Rx-to-OTC switches worldwide?
- Which disease areas do industry professionals believe to hold the most opportunity for switches?
- Which geographies hold the most potential for an OTC product, and which are the most amenable to Rx-to-OTC switching?
Key Reasons to Purchase
- Gain a thorough understanding of Rx-to-OTC switching, including key concepts, the regulatory environment and geographic variations.
- Understand the competitive environment of key disease areas in the OTC product space.
- Identify the drug classes and indications which pharmaceutical professionals around the world believe hold the most opportunity for Rx-to-OTC switching.
- Understand in depth the key trends driving and holding back the OTC market, both globally and within specific geographies.
There are 10 Chapters to deeply display the Rx-to-OTC Switching market.
To find out more of the report or request some customization :
Link to the Inquiry before purchase:https://www.marketintelreports.com/inquiry-before-buying.php?id=cbr0004
Table of Contents-Key Points Covered – Partial paste
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Rx-to-OTC Switching Overview 7
2.1 What is Rx-to-OTC switching? 7
3 Leading Product Categories in the OTC Drugs Market 10
………….
8 Other Geographic Trends and Insights 56
8.1 Australia 56
8.2 Canada 56
8.3 China 57
8.4 Germany 58
8.5 Poland 58
8.6 South Korea 59
8.7 Sweden 59
8.8 Russia 60
8.9 Greatest Revenue-Generating OTC Markets 60
8.10 In Which Countries is Reverse Switching a Possibility? 61
Continued…..
Complete Report Details @https://www.marketintelreports.com/report/cbr0004/current-and-future-trends-in-rxtootc-switching-with-insight-from-key-industry-opinion-leaders
Contact us for any queries on the report:
Lakshmi
Sales Manager
Email : sales@marketintelreports.com
www.marketintelreports.com
Contact Sales: 1-302-261-5343
About us:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Contact Information:
MarketIntelReports
Lakshmi
Tel: 1-302-261-5343
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketIntelReports
Lakshmi
Tel: 1-302-261-5343
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results